Literature DB >> 11879177

The glucose-6-phosphatase system.

Emile van Schaftingen1, Isabelle Gerin.   

Abstract

Glucose-6-phosphatase (G6Pase), an enzyme found mainly in the liver and the kidneys, plays the important role of providing glucose during starvation. Unlike most phosphatases acting on water-soluble compounds, it is a membrane-bound enzyme, being associated with the endoplasmic reticulum. In 1975, W. Arion and co-workers proposed a model according to which G6Pase was thought to be a rather unspecific phosphatase, with its catalytic site oriented towards the lumen of the endoplasmic reticulum [Arion, Wallin, Lange and Ballas (1975) Mol. Cell. Biochem. 6, 75--83]. Substrate would be provided to this enzyme by a translocase that is specific for glucose 6-phosphate, thereby accounting for the specificity of the phosphatase for glucose 6-phosphate in intact microsomes. Distinct transporters would allow inorganic phosphate and glucose to leave the vesicles. At variance with this substrate-transport model, other models propose that conformational changes play an important role in the properties of G6Pase. The last 10 years have witnessed important progress in our knowledge of the glucose 6-phosphate hydrolysis system. The genes encoding G6Pase and the glucose 6-phosphate translocase have been cloned and shown to be mutated in glycogen storage disease type Ia and type Ib respectively. The gene encoding a G6Pase-related protein, expressed specifically in pancreatic islets, has also been cloned. Specific potent inhibitors of G6Pase and of the glucose 6-phosphate translocase have been synthesized or isolated from micro-organisms. These as well as other findings support the model initially proposed by Arion. Much progress has also been made with regard to the regulation of the expression of G6Pase by insulin, glucocorticoids, cAMP and glucose.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11879177      PMCID: PMC1222414          DOI: 10.1042/0264-6021:3620513

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  252 in total

1.  Glucose-6-phosphatase catalytic enzyme inhibitors: synthesis and in vitro evaluation of novel 4,5,6,7-tetrahydrothieno[3,2-c]- and -[2,3-c]pyridines.

Authors:  P Madsen; J M Lundbeck; P Jakobsen; A R Varming; N Westergaard
Journal:  Bioorg Med Chem       Date:  2000-09       Impact factor: 3.641

2.  Type-1c glycogen storage disease is not caused by mutations in the glucose-6-phosphate transporter gene.

Authors:  B Lin; H Hiraiwa; C J Pan; R C Nordlie; J Y Chou
Journal:  Hum Genet       Date:  1999-11       Impact factor: 4.132

Review 3.  Genetic control of morphogenetic and biochemical differentiation: lethal albino deletions in the mouse.

Authors:  S Gluecksohn-Waelsch
Journal:  Cell       Date:  1979-02       Impact factor: 41.582

4.  Effect of P(i) restriction on renal Na(+)-P(i) cotransporter mRNA and immunoreactive protein in X-linked Hyp mice.

Authors:  H S Tenenhouse; J Martel; J Biber; H Murer
Journal:  Am J Physiol       Date:  1995-06

5.  An integrated view of the kinetics of glucose and phosphate transport, and of glucose 6-phosphate transport and hydrolysis in intact rat liver microsomes.

Authors:  W Xie; G van de Werve; A Berteloot
Journal:  J Membr Biol       Date:  2001-01-15       Impact factor: 1.843

6.  Glycogen storage disease type IB: a new model of genetic disorders involving the transport system of intracellular membrane.

Authors:  K Tada; K Narisawa; Y Igarashi; S Kato
Journal:  Biochem Med       Date:  1985-04

7.  Regulation of rat liver glucose-6-phosphatase gene expression in different nutritional and hormonal states: gene structure and 5'-flanking sequence.

Authors:  D Argaud; Q Zhang; W Pan; S Maitra; S J Pilkis; A J Lange
Journal:  Diabetes       Date:  1996-11       Impact factor: 9.461

8.  GLUT8 is a glucose transporter responsible for insulin-stimulated glucose uptake in the blastocyst.

Authors:  M O Carayannopoulos; M M Chi; Y Cui; J M Pingsterhaus; R A McKnight; M Mueckler; S U Devaskar; K H Moley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

9.  Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib.

Authors:  I Gerin; M Veiga-da-Cunha; Y Achouri; J F Collet; E Van Schaftingen
Journal:  FEBS Lett       Date:  1997-12-15       Impact factor: 4.124

10.  Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase.

Authors:  J C Parker; M A VanVolkenburg; C B Levy; W H Martin; S H Burk; Y Kwon; C Giragossian; T G Gant; P A Carpino; R K McPherson; P Vestergaard; J L Treadway
Journal:  Diabetes       Date:  1998-10       Impact factor: 9.461

View more
  122 in total

1.  Deletion of interleukin-6 improves pyruvate tolerance without altering hepatic insulin signaling in the leptin receptor-deficient mouse.

Authors:  Alicia H Clementi; Allison M Gaudy; Teresa A Zimmers; Leonidas G Koniaris; Robert A Mooney
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

2.  Early maternal undernutrition programs increased feed intake, altered glucose metabolism and insulin secretion, and liver function in aged female offspring.

Authors:  Lindsey A George; Liren Zhang; Nuermaimaiti Tuersunjiang; Yan Ma; Nathan M Long; Adam B Uthlaut; Derek T Smith; Peter W Nathanielsz; Stephen P Ford
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-01-25       Impact factor: 3.619

3.  The nucleolar channel system of human endometrium is related to endoplasmic reticulum and R-rings.

Authors:  Nupur Kittur; Gregory Zapantis; Mira Aubuchon; Nanette Santoro; David P Bazett-Jones; U Thomas Meier
Journal:  Mol Biol Cell       Date:  2007-04-11       Impact factor: 4.138

4.  Liver glucose-6-phosphatase proteins in suckling and weaned grey seal pups: structural similarities to other mammals and relationship to nutrition, insulin signalling and metabolite levels.

Authors:  K A Bennett; M Hammill; S Currie
Journal:  J Comp Physiol B       Date:  2013-06-07       Impact factor: 2.200

5.  Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy.

Authors:  Gyongyi O Okechuku; Lawrence R Shoemaker; Monika Dambska; Laurie M Brown; Justin Mathew; David A Weinstein
Journal:  J Inherit Metab Dis       Date:  2017-06-13       Impact factor: 4.982

6.  Evidence for transcriptional regulation of the glucose-6-phosphate transporter by HIF-1alpha: Targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells.

Authors:  Simon Lord-Dufour; Ian B Copland; Louis-Charles Levros; Martin Post; Abhirup Das; Chaitan Khosla; Jacques Galipeau; Eric Rassart; Borhane Annabi
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

7.  Immunodetection of the expression of microsomal proteins encoded by the glucose 6-phosphate transporter gene.

Authors:  Silvia Senesi; Paola Marcolongo; Tamas Kardon; Giovanna Bucci; Andrey Sukhodub; Ann Burchell; Angelo Benedetti; Rosella Fulceri
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

8.  Sequence variation between the mouse and human glucose-6-phosphatase catalytic subunit gene promoters results in differential activation by peroxisome proliferator activated receptor gamma coactivator-1alpha.

Authors:  M M Schilling; J K Oeser; J K Chandy; B P Flemming; S R Allen; R M O'Brien
Journal:  Diabetologia       Date:  2008-06-19       Impact factor: 10.122

9.  Low-Dose Dihydrotestosterone Drives Metabolic Dysfunction via Cytosolic and Nuclear Hepatic Androgen Receptor Mechanisms.

Authors:  Stanley Andrisse; Shameka Childress; Yaping Ma; Katelyn Billings; Yi Chen; Ping Xue; Ashley Stewart; Momodou L Sonko; Andrew Wolfe; Sheng Wu
Journal:  Endocrinology       Date:  2017-03-01       Impact factor: 4.736

10.  Hyperpolarized MRI Visualizes Warburg Effects and Predicts Treatment Response to mTOR Inhibitors in Patient-Derived ccRCC Xenograft Models.

Authors:  Yiyu Dong; Roozbeh Eskandari; Chelsea Ray; Kristin L Granlund; Lidia Dos Santos-Cunha; Vesselin Z Miloushev; Sui Seng Tee; Sangmoo Jeong; Omer Aras; Ying-Bei Chen; Emily H Cheng; James J Hsieh; Kayvan R Keshari
Journal:  Cancer Res       Date:  2018-11-20       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.